Miramar Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Hold
290
0.06% 49
2025
Q4
$312K Sell
290
-10
-3% -$9.56K 0.07% 49
2025
Q3
$229K Hold
300
0.05% 55
2025
Q2
$234K Buy
+300
New +$233K 0.06% 57
2023
Q4
Sell
-2,352
Closed -$1.26M 65
2023
Q3
$1.26M Hold
2,352
0.34% 33
2023
Q2
$1.1M Sell
2,352
-50
-2% -$21K 0.28% 32
2023
Q1
$825K Hold
2,402
0.21% 38
2022
Q4
$879K Hold
2,402
0.23% 42
2022
Q3
$873K Buy
2,402
+11
+0.5% +$3.48K 0.24% 46
2022
Q2
$775K Sell
2,391
-69
-3% -$20.7K 0.22% 50
2022
Q1
$704K Buy
2,460
+1,092
+80% +$281K 0.19% 61
2021
Q4
$378K Sell
1,368
-50
-4% -$12.7K 0.13% 45
2021
Q3
$328K Hold
1,418
0.13% 43
2021
Q2
$375K Sell
1,418
-1,198
-46% -$241K 0.15% 42
2021
Q1
$489K Sell
2,616
-2,410
-48% -$471K 0.22% 37
2020
Q4
$1.03M Buy
+5,026
New +$750K 0.46% 37

Other funds holding LLY

Miramar Capital's LLY Position: Q1 2026 in Review

Miramar Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 290 shares worth $267K. The position accounts for 0.06% of the portfolio, ranked #49.

Miramar Capital first reported a position in LLY in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.26M in Q3 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Miramar Capital held 290 shares of Eli Lilly worth $267K as of Q1 2026.
  • Miramar Capital left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.06% of Miramar Capital's portfolio in Q1 2026, its #49 holding.
  • Miramar Capital first reported a position in Eli Lilly in Q4 2020 and has held it in 16 quarters since.
  • Miramar Capital's Eli Lilly position peaked at $1.26M in Q3 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Miramar Capital's 13F filing for Q1 2026, filed 11 May 2026.